⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GKOS News
Glaukos Corporation
Form 8-K
sec.gov
GKOS
Glaukos Receives Permanent J-code for Epioxa™
businesswire.com
GKOS
Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29
businesswire.com
GKOS
Perimeter Systems, Inc. Launches as Global, End-to-End Biosecurity Infrastructure Platform to Address Escalating Global Biodefense Needs
prnewswire.com
GKOS
PLTR
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
businesswire.com
GKOS
Orsini to Serve as Single-Source Specialty Pharmacy Partner for Glaukos' Epioxa™
prnewswire.com
GKOS
Glaukos Announces Commercial Availability of Epioxa ™, a Transformative Innovation in Interventional Keratoconus Care
businesswire.com
GKOS
Form 8-K
sec.gov
GKOS
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
GKOS
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
GKOS